ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,132Medicare Part D Prescriptions Filled, Including Refills

Rank: 113 out of 2456

$632K Total Retail Price of All Prescriptions

Rank: 140 out of 2456

617 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 617 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 617 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 8,932 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 477 344 1 2
LISINOPRIL 469 356 2 1
OMEPRAZOLE 428 273 3 3
WARFARIN SODIUM 422 368 4 9
LEVOTHYROXINE SODIUM 359 292 5 4
METOPROLOL TARTRATE 320 248 6 10
HYDROCODONE-ACETAMINOPHEN 317 89 S3 7 20
ATENOLOL 311 285 8 6
FUROSEMIDE 289 254 9 8
METFORMIN HCL 288 186 10 11
AMLODIPINE BESYLATE 270 216 11 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 222 169 12 41
ZOLPIDEM TARTRATE 186 129 13 28
ATORVASTATIN CALCIUM 184 176 14 12
IBUPROFEN 183 66 15 52
GABAPENTIN 183 74 15 16
ATENOLOL-CHLORTHALIDONE 172 120 17 176
HYDROCHLOROTHIAZIDE 164 156 18 7
CITALOPRAM HBR 158 104 19 14
TRAMADOL HCL 134 50 20 24
DIOVAN 124 122 21 26
OXYCODONE HCL 118 45 S2 22 38
METOPROLOL SUCCINATE 118 101 22 13
GLYBURIDE 105 72 R 24 40
SERTRALINE HCL 98 65 25 21
TAMSULOSIN HCL 97 81 26 32
ALLOPURINOL 93 83 27 27
ISOSORBIDE MONONITRATE ER 90 90 28 48
OLANZAPINE 83 66 29 57
DIGOXIN 81 75 30 49
GEMFIBROZIL 80 51 31 93
LEVETIRACETAM 75 25 32 90
FLUOXETINE HCL 75 40 32 45
PREDNISONE 74 66 34 39
LORAZEPAM 72 72 35 67
AZITHROMYCIN 72 49 35 60
LANTUS 72 38 35 44
OXYCODONE-ACETAMINOPHEN 72 21 S2 35 35
LOVASTATIN 72 61 35 34
DONEPEZIL HCL 72 72 35 23
TRAZODONE HCL 68 54 41 17
POLYETHYLENE GLYCOL 3350 66 56 42 64
PROAIR HFA 65 32 43 22
AMLODIPINE BESYLATE-BENAZEPRIL 65 40 43 144
ADVAIR DISKUS 64 61 45 36
FINASTERIDE 64 55 45 66
DIOVAN HCT 61 59 47 139
NIFEDIPINE ER 59 53 48 61
RANITIDINE HCL 59 26 48 31
PRAVASTATIN SODIUM 58 43 50 15
FLUTICASONE PROPIONATE 57 45 51 30
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 41 51 147
PANTOPRAZOLE SODIUM 57 40 51 37
LOSARTAN POTASSIUM 56 46 54 18
ENALAPRIL MALEATE 56 41 54 70
OXYCODONE HCL-ACETAMINOPHEN 55 18 S2 56 101
MORPHINE SULFATE ER 54 23 S2 57 98
DOXAZOSIN MESYLATE 52 49 58 71
CARVEDILOL 52 52 58 54
CYMBALTA 51 41 60 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 13, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.